Skip to main content

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Cory Ellspermann

Cory Ellspermann is recorded as CFO and Board Member at Inmune Bio, Inc. (INMB). Inmune Bio, Inc. reported in an 8-K filed November 28, 2025 that Cory Ellspermann was appointed Chief Financial Officer, effective November 1, 2025. The proxy statement of Inmune Bio, Inc. reports total compensation of $619,227 for Cory Ellspermann in fiscal 2025, including a base salary of $190,938. Cory Ellspermann has spoken on 2 earnings calls across 1 company, most recently for Inmune Bio, Inc. on March 31, 2026.

“INmune Bio Inc. (the "Company") is pleased to offer you continued at-will employment in the position of Chief Financial Officer on the terms and conditions set forth in this letter agreement (the "Agreement").”
Inmune Bio, Inc. Form 8-K, filed November 28, 2025 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Inmune Bio, Inc.

Other people whose current roles at this company are on record from its filings.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 Inmune Bio, Inc. (INMB) $190,938 $619,227

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.